resourceId,insertName,vectorType,vectorBackbone,promoter,insertSpecies,insertEntrezId,selectableMarker,copyNumber,gRNAshRNASequence,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
RES2d71f332,dLight1.2,Viral,AAV,hSyn,,,,,,dLight1.2,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-hSyn-dLight1.2 Addgene Plasmid#: 111068 RRID: Addgene_111068 Gift on Lin Tian; produced by UC Davis Vector Core,0.95,Accept,Experimental Usage
RES7f002cca,hChR2(H134R)-EYFP,Viral,AAV,hSyn,,,,,,hChR2(H134R)-EYFP,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-hSyn-hChR2(H134R)-EYFP Addgene Plasmid#: 26973 RRID: Addgene_26973 Gift of Karl Deisseroth,0.9,Accept,Experimental Usage
RESd3b0b74a,Cre,Viral,AAV9,Th,,,,,,Cre,PMID:31545171 | PMID:35589737 | PMID:20200958 | PMID:19191334 | PMID:28392281 | PMID:25772366 | PMID:23685747 | PMID:17924978 | PMID:38127282 | PMID:25043591,10.7554/eLife.48983 | 10.1038/s41467-022-30466-6 | 10.1002/jbmr.42 | 10.1002/glia.20845 | 10.1016/j.expneurol.2017.04.001 | 10.1016/j.celrep.2015.02.041 | 10.1038/ng.2641 | 10.1111/j.1750-3639.2007.00105.x | 10.1158/1078-0432.CCR-23-2548 | 10.1002/jbmr.2316,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1. | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Human stem cell modeling in neurofibromatosis type 1 (NF1). | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"AAV9-Th-PI-Cre-SV40 Addgene Plasmid#: 107788 RRID: Addgene_107788 Addgene viral prep#: 107788-AAV9 | DRG-NSCs were isolated from E13.5 embryo DRG/nerve roots, and were infected with Ad-CMV-Cre | infection with adenovirus Ad5-CMV-Cre or Ad5-CMV-eGFP (2500 viral particles per cell; Vector Development Lab) | The Nf1 gene was inactivated in passage 1 Nf1flox/flox astrocytes by infection with adenovirus (Ad5) containing Cre recombinase | excisable lentiviral vectors have been developed using Cre/loxP technology | Wild-type and Nf1 −/− NSCs were generated from Nf1 flox/flox mouse brains following infection with Ad5-LacZ and Ad5-Cre adenovirus | a Schwann cell specific Cre-recombinase controlled by the CNP promoter (Cnp-Cre) | Cre recombinase was targeted to the mouse leptomeninges by direct injection of 3 µL (1 × 10 8 plaque‐forming units) of adCre suspension | Cre recombinase expressing adenovirus (Ad5CMVCre-GFP High Titer, University of Iowa Viral Vector Core) | containing either Ad5-CMV-GFP or Ad5-CMV-cre (Vector development lab, Baylor College of Medicine)",0.9,Accept,Experimental Usage
RES051bb136,eNpHR3.0-eYFP,Viral,AAV-DJ,Ef1α,,,,,,eNpHR3.0-eYFP,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-DJ-Ef1α-DO-eNpHR3.0-eYFP-WPRE-pA Addgene Plasmid#: 37087 RRID: Addgene_37087 Gift of Bernardo Sabatini,0.9,Accept,Experimental Usage
RES5fb8675b,mCherry,Viral,AAV-DJ,Ef1α,,,,,,mCherry,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-DJ-Ef1α-DO-mCherry-WPRE-pA Addgene Plasmid#: 37119 RRID: Addgene_37119 Gift of Bernardo Sabatini,0.9,Accept,Experimental Usage
RESb1a15122,tTA,Viral,AAV,ihSyn1,,,,,,tTA,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-ihSyn1-tTA-WPRE Addgene Plasmid#: 99120 RRID: Addgene_99120 | pAAV-Th-tTA-WPRE Addgene Plasmid#: 133268 RRID: Addgene_133268,0.9,Accept,Experimental Usage
RES31ab06c0,mRuby,Viral,AAV,TRE,,,,,,mRuby,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-TRE-mRuby-WPRE Addgene Plasmid#: 99114 RRID: Addgene_99114,0.9,Accept,Experimental Usage
RES8a7d11db,mTurquoise,Viral,AAV,TRE,,,,,,mTurquoise,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-TRE-mTurquoise-WPRE Addgene Plasmid#: 99113 RRID: Addgene_99113,0.9,Accept,Experimental Usage
RESb308811a,GFP,Viral,AAV5,CMV,,,GFP,,,GFP,PMID:40590220 | PMID:31545171 | PMID:21072183 | PMID:39129390 | PMID:24509877 | PMID:20049725 | PMID:25043591,10.1172/JCI188932 | 10.7554/eLife.48983 | 10.1371/journal.pone.0013791 | 10.1002/1878-0261.13704 | 10.1038/onc.2013.506 | 10.1002/emmm.200900027 | 10.1002/jbmr.2316,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"control (GFP; AAV5-CMV-GFP, UNC) or Cre-recombinase fused to GFP (CRE; AAV5-CMV-Cre-GFP, UNC) | pAAV-Th-GFP-WPRE Addgene Plasmid#: 99128 RRID: Addgene_99128 | subcloned as a Bgl II/Xho I fragment into the retroviral expression vector pBMN-I-GFP | co‐transfected with the pl018 plasmid to express Cas9 and the sgRNA (CGCTTCTCCCTTGTCATATC) and pAct‐GFP plasmid | MPNST cells were infected with purified Ad-NF1-GRD or control Ad-GFP, in triplicate | lentiviral particles containing shRNAs targeting SOX9 (Open Biosystems; TRC library) or GFP (Addgene) | containing either Ad5-CMV-GFP or Ad5-CMV-cre (Vector development lab, Baylor College of Medicine)",0.95,Accept,Experimental Usage
RES74ca0a0c,iCAP-PHP.eB,Plasmid,pUCmini,,,,,,,iCAP-PHP.eB,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pUCmini-iCAP-PHP.eB Addgene Plasmid#: 103005 RRID: Addgene_103005,0.9,Accept,Experimental Usage
RES7069b02e,dLight1,Viral,,,,,,,,dLight1,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,We employed the genetically encoded optical dopamine sensor dLight1 to monitor dopaminergic neurotransmission in the ventral striatum of NF1 mice,0.95,Accept,Experimental Usage
RES1037d2b5,LacZ,Viral,,,,,Control shRNA,,,LacZ,PMID:32642734 | PMID:19191334 | PMID:25772366,10.1093/noajnl/vdz026 | 10.1002/glia.20845 | 10.1016/j.celrep.2015.02.041,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,Cells were transduced with either lentiviral control shLacZ (Genome Institute at Washington University) | Control Nf1flox/flox astrocytes (wild-type) were treated identically with an adenovirus encoding LacZ | Wild-type and Nf1 −/− NSCs were generated from Nf1 flox/flox mouse brains following infection with Ad5-LacZ and Ad5-Cre adenovirus,0.9,Accept,Experimental Usage
RES3662578a,Trim23,Viral,,,,,,,,Trim23,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,"separate lentiviral shRNAs targeting Trim23 (Sigma; TRCN0000308323, TRCN0000308321, TRCN0000308320)",0.95,Accept,Experimental Usage
RESe7247e8c,shNF1,Viral,,,Human,,,,,shNF1,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"were infected with sh NF1 1–3 lentiviral particles (Sigma; 39714, 39715, 39717)",0.95,Accept,Experimental Usage
RES0d91d4ea,shCOL1A2,Viral,,,Human,,,,,shCOL1A2,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Human sh COL1A2 and mouse sh Col1a2 lentiviral particles (TRCN0000090043; TRCN0000090045; TRCN0000335210),0.95,Accept,Experimental Usage
RES38d2bed4,pCR2.1-TOPO,Plasmid,pCR2.1,,,,,,,pCR2.1-TOPO,PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The PCR products were cloned in the pCR2.1-TOPO-vector (Invitrogen) and transformed into TOP-10F' cells.,0.9,Accept,Experimental Usage
RES97ca2fea,NF1 gRNA,Other,,,,,,,,NF1 gRNA,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,We targeted NF1's RASGAP GRD domain with clustered regularly interspaced short palindromic repeat (CRISPR) guides to the 21st exon,0.85,Accept,Experimental Usage
RES14a8b78a,eGFP,Viral,Ad5,CMV,,,,,,eGFP,PMID:20200958 | PMID:21949590,10.1002/jbmr.42 | 10.2478/v10134-010-0025-8,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,infection with adenovirus Ad5-CMV-Cre or Ad5-CMV-eGFP (2500 viral particles per cell; Vector Development Lab) | Neurite outgrowth was determined from low-density hippocampal neurons transfected with EGFP using Lipofectamine,0.9,Accept,Experimental Usage
RES4701a839,NF1 isoform 2,Plasmid,,,Human,,,,,NF1 isoform 2,PMID:31836666 | PMID:36689660,10.1074/jbc.RA119.010934 | 10.1073/pnas.2208960120,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,"Entry clones were produced by PCR amplification of portions of the NF1 gene from Addgene construct 70423, which contains a codon-optimized version of human NF1 isoform 2 | Point mutations in NF1 isoform-2 were generated by PCR mutagenesis of Addgene plasmid 70423.",0.9,Accept,Experimental Usage
RESfdb6ba4d,truXTRAC FFPE DNA,Other,,,,,,,,truXTRAC FFPE DNA,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,DNA extraction from FFPE tissue samples was performed using the Covaris truXTRAC FFPE DNA kit with the E220 Evolution-focused ultrasonicator system,0.85,Accept,Experimental Usage
RES63ecf018,Kapa HyperPlus,Other,,,,,,,,Kapa HyperPlus,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"Exome libraries were prepared using the Roche Kapa HyperPlus kit, captured using the HyperExome kit Roche",0.85,Accept,Experimental Usage
RESacb583a3,HumanMethylationEPIC,Other,,,,,,,,HumanMethylationEPIC,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Tumor DNA derived from fresh-frozen tumors and paired normal nerve samples was used for whole-genome DNA methylation array profiling using the HumanMethylationEPIC beadchip platform,0.85,Accept,Experimental Usage
RESed7ca552,EZ DNA methylation Gold,Other,,,,,,,,EZ DNA methylation Gold,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,350 ng of DNA were bisulfite converted using the Zymo EZ DNA methylation Gold kit (Zymo Research Corp.),0.85,Accept,Experimental Usage
RESb721c2c2,oligo-dT,Other,,,,,,,,oligo-dT,PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"mRNA was selected by running total RNA over oligo-dT columns (Invitrogen, Carlsbad, CA)",0.8,Accept,Experimental Usage
RES62bd558c,PCR master mix,Other,,,,,,,,PCR master mix,PMID:18670322 | PMID:21726432,10.1097/MLG.0b013e318177e20b | 10.1186/1741-7015-9-82,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Taqman Universal PCR Master Mix (2× buffer containing polymerase; Applied Biosystems, Foster City, CA) | TaqMan Universal PCR Master Mix was then performed on an ABI PRISM 7900 Cycler (Applied Biosystems)",0.85,Accept,Experimental Usage
RES8e819d3d,GLuc,Viral,,,Other,,,,,GLuc,PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"NF2 −/− cells should be transduced before use so they express the GLuc reporter gene, which is a secreted reporter that can be detected in the blood of tumor-bearing animals. | GLuc vector and assay kits are commercially available from various biotech companies, such as Thermo Fisher Scientific (cat. no. 16146) and New England BioLabs (cat. no. N8084S).",0.85,Accept,Experimental Usage
RES2bff6dab,sgRNA,Plasmid,pCRISPRia-v2,,,,,,,sgRNA,PMID:38216572 | PMID:27956228 | PMID:35789380 | PMID:39415595,10.1038/s41467-024-44755-9 | 10.1053/j.gastro.2016.12.002 | 10.1158/2159-8290.CD-21-1671 | 10.1242/dmm.050862,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Subsequent gene specific knockdowns were achieved by individually cloning single-guide RNA (sgRNA) protospacer sequences into the pCRISPRia-v2 vector (#84832, Addgene) | sgRNA oligos (IDT) were annealed and cloned into the pX330 vector (addgene 42230) or lentiV2 (addgene 52961) | Control and SUZ12 sgRNA targeting the VEFS functional domain were cloned into pL-CRISPR.EFS.Blast (plasmid was generated by replacing tagRFP in Addgene Plasmid #57819) | gRNAs targeting zebrafish nf2a/b were validated and cloned in the pU6(x):sgRNA#(x) vectors",0.9,Accept,Experimental Usage
RESc7f2e43a,NF2,Viral,CSCW2,,Human,,,,,NF2,PMID:33273014 | PMID:29715273 | PMID:30274821 | PMID:26219339 | PMID:24595234,10.1074/jbc.RA120.014960 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.18632/oncotarget.4858 | 10.1371/journal.pone.0090853,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,"full length cDNA coding sequence of NF2 (isoform 1, NCBI accession # NM_000268) cloned into the lentiviral vector CSCW2 | the plasmid pcNf2hflag containing a CMV promoter and a neomycin resistance cassette was used | The plasmids HA-tagged NF2 (a gift from Dr. Y. J. LU, Tongji University, China) | transfected using program U-023 with lenti-CRISPR-NF2_sg1 expressing a single guide RNA targeting human NF2 exon 8 | Transgenes expressing the indicated NF2 proteins were cloned with N-terminal Flag epitope tags in the pUASt transformation vector.",0.9,Accept,Experimental Usage
RESfe394f0d,apterous-Gal4,Other,,,,,,,,apterous-Gal4,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,ectopic expression of the NF2 isoforms under the control of the apterous-Gal4 driver,0.85,Accept,Experimental Usage
RES7663bdf6,H-RAS,Plasmid,,,,,,,,H-RAS,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,HA-H-RAS was expressed together with either wild-type (WT) or variant NF in COS-7 or HEK 293 T cells,0.85,Accept,Experimental Usage
RESc85d1396,SPRED1,Plasmid,,,,,,,,SPRED1,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,FLAG-SPRED1 (WT or variant) and NF (WT or variant) were coexpressed in HEK 293 T cells,0.85,Accept,Experimental Usage
RESd888775d,RAF-RBD,Other,,,,,,,,RAF-RBD,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,GTP-bound RAS was subsequently isolated using glutathione-agarose beads coated with recombinant GST-RAF-RBD,0.85,Accept,Experimental Usage
RES0342e628,BNIP3,Other,,,,,,,,BNIP3,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,BNIP3 and HIF-1α siRNA (siGENOME SMARTPool) was purchased from Thermo Scientific,0.85,Accept,Experimental Usage
RESd76e0e6e,HIF-1α,Other,,,,,,,,HIF-1α,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,BNIP3 and HIF-1α siRNA (siGENOME SMARTPool) was purchased from Thermo Scientific,0.85,Accept,Experimental Usage
RES5b74c968,Nf1,Other,,,,,,,CCAGGACATCTCCAAGGATG,Nf1,PMID:32461556 | PMID:38481529 | PMID:39890807 | PMID:34646065 | PMID:37446790 | PMID:34011935 | PMID:29670214 | PMID:37140985 | PMID:36241865,10.1038/s41467-020-16432-0 | 10.3389/fcell.2024.1359561 | 10.1038/s41598-024-84493-y | 10.1155/2021/9386823 | 10.3390/molecules28135128 | 10.1038/s41419-021-03802-9 | 10.1038/s41598-018-24310-5 | 10.1172/JCI168227 | 10.1038/s12276-022-00850-9,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Survival and | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Restoring functional neurofibromin by protein transduction. | Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"Nf1 Exon 8, F CCAGGACATCTCCAAGGATG | sgRNA1 (5′-TAACTGCGCAACCTTCTTTA-3′) and sgRNA2 (5′-GTTAGCAGTTATAAATAGCC-3′) target the exon 6 of NF1 gene | The wild type (WT) mNf1 cDNA plasmid was developed by GeneCopoeia and is commercially available. The full-length, endogenous mouse cDNA (mNf1) containing Nf1 isoform 2 | all samples were screened for large deletions using four TaqMan NF1 copy-number assays across the gene (ThermoFisher; Hs05477010, Hs06413401, Hs05512625, and Hs03960106) | CRISPR/Cas9 single-vector lentivirus was purchased from GeneChem (Shanghai, China) | Small interfering RNA (siRNA) targeting NF1 (s221793) | synthetic gene (GeneArt) encoding the human full-length NF1 (synNF1) | Two predesigned siRNAs against human NF1 were purchased from MilliporeSigma (SASI_Hs01_00129008 and SASI_Hs01_00129006). | cells were transfected with the control lentivirus (LV-vector), NF-1 sgRNA-CAS9 lentivirus (LV-NF-1), Rictor sgRNA-CAS9 lentivirus (LV-Rictor) | synthetic gene (GeneArt) encoding the human full-length NF1 (synNF1) was cloned into the pFastBacHta (Life Technology) vector",0.95,Accept,Experimental Usage
RES1b294e26,Cas9,Viral,LentiCas9-Blast,,,,Blasticidin,,,Cas9,PMID:39269317 | PMID:34415582 | PMID:34630515 | PMID:37164978 | PMID:32642733 | PMID:39129390 | PMID:39890807 | PMID:41036607 | PMID:41023593,10.1158/1078-0432.CCR-24-1750 | 10.1002/glia.24075 | 10.3389/fgene.2021.721045 | 10.1038/s41467-023-38432-6 | 10.1093/noajnl/vdz061 | 10.1002/1878-0261.13704 | 10.1038/s41598-024-84493-y | 10.1158/1535-7163.MCT-24-1053 | 10.1186/s10020-025-01353-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,"The LentiCRISPR-v2 (RRID: Addgene_52961), LentiGuide-Puro (RRID: Addgene_52963), and LentiCas9-Blast (RRID: Addgene_52962) vectors were purchased from Addgene | We generated hsp70:dll4-P2A-GFP, hsp70:GFP-P2A-dlb, hsp70:GFP-P2A-hey1, hsp70:id2b-P2A-GFP, ubi:Cas9, u6:dll4-gRNAs and 1,2 u6:n3-gRNAs transgenic fish | 1.95μm Cas9 (Cas9 Nuclease V3; IDT) | The injection solution contained gRNAs, S. pyogenes Cas9 mRNA (PNA Bio Inc., Thousand Oaks, CA or Millipore Sigma, Burlington, MA) | To generate CRISPR/Cas9-modified ipNF06.2A cell lines, sequences were subcloned into pX330 | pX330-U6-Chimeric_BB-CBh-HSpCas0 (Addgene) | WT S2R+ cells were co‐transfected with the pl018 plasmid to express Cas9 | we utilized CRISPR Cas9 targeting of NF1 exon 2 to create inactivating indels in NF1 on both alleles | One million cells were electroporated (1 pulse of 1400V for 30 ms) with 2 µg Flag-hCas9 | Conditional gene expression, CRISPR-CAS9, and shRNA-mediated knockdown were used to perform gain/loss-of-function experiments",0.95,Accept,Experimental Usage
RESb0129c8a,PrimeSTAR GXL,,,,,,,,,PrimeSTAR GXL,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"the targeted region was PCR amplified with the hotstart PrimeSTAR GXL DNA polymerase (Takara Bio Inc., Mountain View, CA)",0.85,Accept,Experimental Usage
RESbdfd2ddc,NHE1,Other,,,,,,,,NHE1,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"NHE1 siRNA: ON-TARGET SMART pool (Thermo Scientific); NBCn1 siRNA (SASI_Hs01_00030755, Sigma-Aldrich)",0.85,Accept,Experimental Usage
RES11f352ff,Merlin,Other,,,,,,,5′-CCUCAAAGCUUCGUGUUAA-3′,Merlin,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Merlin siRNA (SASI_Hs_01_00188862, Sigma) sense sequence 5′-CCUCAAAGCUUCGUGUUAA-3",0.9,Accept,Experimental Usage
RES5991d509,V-CSCW2,Viral,CSCW2,,,,,,,V-CSCW2,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Ben-Men-1 cells were transduced with either NF2-CSCW2 or V-CSCW2,0.8,Accept,Experimental Usage
RES77d62ff2,MM-121,,,,,,,,,MM-121,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,MM-121 (generously provided by Merrimack Pharmaceuticals),0.85,Accept,Experimental Usage
RESbc8cc751,SA3,,,,,,,,,SA3,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,"mice that were treated with the STING agonist SA3 (HY-103665, MedChemExpress)",0.9,Accept,Experimental Usage
RES98550cd1,GRDC24,Viral,AAV,CBh,,,,,,GRDC24,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,pscAAV-GFP and pscAAV-GRDC24 (2163 bp between ITRs) were used to generate AAV-GFP and AAV-GRDC24,0.9,Accept,Development
RES508e038b,NF-targeting capsid,Viral,AAV,,,,,,,NF-targeting capsid,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"This tailored vector, AAV-NF, exhibits greatly reduced liver uptake, enhanced tumor targeting across various NF1-related MPNST",0.95,Accept,Development
RES35408b12,Human Phospho-RTK Array,Other,,,,,,,,Human Phospho-RTK Array,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,"MPNST cells were seeded in 15-cm dishes, allowed cell attachment overnight, treated the next day with the desired drug concentrations, harvested at the experiment endpoint, and lysed using the lysis buffer provided by Human Phospho-RTK Array Kit (R&D)",0.85,Accept,Experimental Usage
RESb9653fa2,CRISPR-Cas9,Viral,LentiCRISPR-v2,,,,Puromycin,,,CRISPR-Cas9,PMID:39269317 | PMID:39129390 | PMID:35393510,10.1158/1078-0432.CCR-24-1750 | 10.1002/1878-0261.13704 | 10.1038/s41418-022-00991-4,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"The LentiCRISPR-v2 (RRID: Addgene_52961), LentiGuide-Puro (RRID: Addgene_52963), and LentiCas9-Blast (RRID: Addgene_52962) vectors were purchased from Addgene | NF1‐sg2 (ACACTGGAAAAATGTCTTGC), a sgRNA targeting human NF1 exon 3 in the lentiCRISPR v1 plasmid | Oligonucleotide pairs were annealed and cloned into the transfer plasmid lentiCRISPRv2 (Addgene, Watertown, MA, USA, #52961)",0.95,Accept,Experimental Usage
RES7892bc60,Guide RNA,Viral,LentiGuide-Puro,,,,Puromycin,,,Guide RNA,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,"The LentiCRISPR-v2 (RRID: Addgene_52961), LentiGuide-Puro (RRID: Addgene_52963), and LentiCas9-Blast (RRID: Addgene_52962) vectors were purchased from Addgene",0.95,Accept,Experimental Usage
RESdcd0e8c4,dNf1,Transposon,,UAS,Drosophila,,,,,dNf1,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The UAS‐dNf1 transgene encodes full‐length dNf1 cDNA corresponding to the RF isoform,0.9,Accept,Experimental Usage
RES8454337b,Human All Exon capture probes,Other,,,,,,,,Human All Exon capture probes,PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"Sequencing libraries were generated from 1 μg genomic DNA using Agilent SureSelect Human All Exon kit (Agilent Technologies, California, USA)",0.85,Accept,Experimental Usage
RES4e80b0f7,Fluc and mCherry,Viral,,,,,mCherry,,,Fluc and mCherry,PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,,These cell lines have been transduced with lentivirus expressing Fluc and mCherry genes as described previously,0.85,Accept,Experimental Usage
REScd62db3c,L-[18F]FETrp,,,,,,,,,L-[18F]FETrp,PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"We studied a fluorine-18 labeled tryptophan positron emission tomography (PET) radiotracer, 1-(2-[18F]FETrp",0.9,Accept,Experimental Usage
RES5d6244ac,PDLIM2 shRNA,Plasmid,pLKO.1-puro,,,,Puromycin,,,PDLIM2 shRNA,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Five different shRNA clones were tested... cloned into the plasmid pLKO.1-puro,0.9,Accept,Experimental Usage
RESc32e5f74,λ-phosphatase,,,,,,,,,λ-phosphatase,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Protein dephosphorylation was achieved by treating 20 μg of protein lysate with λ-phosphatase (New England Biolabs),0.85,Accept,Experimental Usage
RESfe7916fc,Cre and gRNAs,Viral,pLenti,CMV,,,GFP,,,Cre and gRNAs,PMID:39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,,"We then prepared lentivirus vector pLentiCre/gRNA, which could express the elements blocking the function of four genes: Nf2, P15 | we constructed an AAV vector of pAAVCre/gRNA, which could import Cre and the four gRNAs",0.9,Accept,Development
RES9b874e05,empty vector,Plasmid,pcDNA3.1,,,,,,,empty vector,PMID:29715273 | PMID:32438526,10.1371/journal.pone.0196726 | 10.1002/lary.28671,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,"An empty vector pcDNA3.1 was used as a control | Adenovirus (Ad) CMVempty vector (EV) at 5 × 109 pfu/mL, AdCMVNeuroD1 at 2 × 109 pfu/mL",0.85,Accept,Experimental Usage
RESe1af3877,NF1-GRD,Viral,Adenovirus,,,,,,,NF1-GRD,PMID:24509877 | PMID:35393510 | PMID:16835260 | PMID:38000020,10.1038/onc.2013.506 | 10.1038/s41418-022-00991-4 | 10.1093/hmg/ddl165 | 10.1126/sciadv.adg8876,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"MPNST cells were infected with purified Ad-NF1-GRD or control Ad-GFP, in triplicate, for 2 h in serum-free medium | NF1-GRD sequence was introduced in Nf1−/− MEFs using the pMSCV-GRD vector | a virus expressing the full-length NF1 GTPase-activating related domain (NF1 GRD) and pac (MSCV-NF1 GRD-pac) | The human NF1-GRD was amplified using the genomic deoxyribonucleic acid (gDNA) from HEK293T as polymerase chain reaction template and subcloned into TTIGFP-MLUEX vector",0.9,Accept,Experimental Usage
RES747f90be,MAF,Viral,Lentivirus,,,,mCherry,,,MAF,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,"Constitutive expression used mCherry tagged MAF (EX-Y2046-Lv111, GeneCopoeia) and mCherry control lentivirus",0.95,Accept,Experimental Usage
RESbb6fa284,MAF ORF,Viral,pLVX-Tight-Puro,,,,Puromycin,,,MAF ORF,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Inducible expression used lentiviral vectors containing the MAF ORF or empty pLVX-Tight-Puro vector (GeneCopoeia),0.9,Accept,Experimental Usage
RES15a9cf58,Tet-On,Viral,pLVX,Tet-inducible,,,,,,Tet-On,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,in a modified pTight backbone (Clonetech) with pLVX-Tet-On doxycycline inducible vector (Clonetech),0.9,Accept,Experimental Usage
RESa1092b09,AP-1 luciferase,Plasmid,,AP-1,,,,,,AP-1 luciferase,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Cells were transfected using FuGENE HD (Roche) with 100ng per well of an AP-1 luciferase (Stratagene) reporter vector,0.9,Accept,Experimental Usage
RESdf9ab1bb,pLKO.1,Plasmid,pLKO.1,,,,,,,pLKO.1,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,"Lentivirus packaging, envelope and control non-hairpin (NHP) pLKO.1 plasmids (Addgene)",0.85,Accept,Experimental Usage
RES2f759dfb,shRHAMM,Viral,,,,,,,,shRHAMM,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,shRNA against RHAMM and TPX2 (Sigma),0.85,Accept,Experimental Usage
RESff1be36a,shTPX2,Viral,,,,,,,,shTPX2,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,shRNA against RHAMM and TPX2 (Sigma),0.85,Accept,Experimental Usage
RES57e3d7c5,ZEB1,Other,,,,,,,,ZEB1,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For siRNA knockdown targeting ZEB1 (Sigma-Aldrich, SASI_Hs02_00330526, SASI_Hs02_00330527, SASI_Hs02_00330530) | T265, was infected by nontarget control or lentiviral vectors carrying ZEB1 shRNA lentivirus for 48 hours",0.9,Accept,Experimental Usage
RES7b3e5bd7,ALDH1A1,Other,,,,,,,,ALDH1A1,PMID:36322658 | PMID:36148553,10.1126/sciadv.abo5442 | 10.1093/brain/awac342,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,"ALDH1A1 (Sigma-Aldrich, SASI_Hs01_00244055, SASI_Hs01_00244056, SASI_Hs02_00303091) in MPNST cell lines | ALDH1A1 (TRCN0000026415)—5′-GCCAAATCATTCCTTGGAATTT-3′",0.9,Accept,Experimental Usage
RESc43f717a,StrepII tag,Other,,,,,,,,StrepII tag,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"We utilized a StepTactin XT System from IBA Lifesciences (Gottingen, Germany). Whole cell lysates were generated by collecting cells and lysing them",0.85,Accept,Experimental Usage
RES0ba17ee2,M-PER,Other,,,,,,,,M-PER,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"Global protein extracts were attained using M-PER™ Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Cat.# 78501)",0.8,Accept,Experimental Usage
RES0680f2a2,BCA,Other,,,,,,,,BCA,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"and quantified using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Cat.# PI23225)",0.8,Accept,Experimental Usage
RES17bd5adf,NF1-targeting TALEN,Other,,,,,,,,NF1-targeting TALEN,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,TALENs were designed to flank the region of NF1 in exon 41. Ossabaw minipig fetal fibroblasts isolated from day 38 embryos were transfected with TALENs,0.85,Accept,Experimental Usage
RES72375016,Gentamicin,,,,,,,,,Gentamicin,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Gentamicin (Sigma) and G418 (Corning) were reconstituted in sterile deionized water to a stock concentration of 50 mg/mL,0.9,Accept,Experimental Usage
RES635b74af,NF1 DLR,Plasmid,,,Human,,,,,NF1 DLR,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,The NF1 DLR plasmid was kindly provided by David Bedwell at University of Alabama. The R1497X Renilla-NF1-R1947X-Firefly insert contains 30 nucleotides,0.95,Accept,Experimental Usage
RES5b367951,PBSB,Transposon,,,,,Hygromycin,,,PBSB,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,we used Gateway cloning to transfer the DLR insert to a hygromycin-resistant PiggyBac Sleeping Beauty (PBSB) transposon vector,0.85,Accept,Experimental Usage
RES820a3434,UPF1,Other,,,,,,,CUGUAAUGGACGUGGAAAUUU,UPF1,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"cells were transfected with 50 nm of siRNA targeting UPF1. In a pilot experiment, three custom and non-overlapping UPF1 duplexes were tested",0.9,Accept,Experimental Usage
RESa77ce9e5,EdU,,,,,,Alexa Fluor 488,,,EdU,PMID:40684195 | PMID:34040258 | PMID:34010628,10.1186/s40478-025-02075-z | 10.1038/s41586-021-03580-6 | 10.1016/j.stem.2021.04.029,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"EdU detection was performed on 14 μm-thick cryosections using the Click-IT Plus EdU Alexa Fluor 488 Imaging Kit (Thermo Fisher Scientific) | EdU proliferation assay was performed using the Click-iT EdU Alexa Fluor 594 imaging kit (Thermo Fisher Scientific C10339) | The incorporated EdU were stained on top of BrdU staining with Click-iT™ EdU Cell Proliferation Kit for Imaging (ThemoFisher, Cat# C10337)",0.85,Accept,Experimental Usage
RESa2ad8ee9,Lipofectamine,Other,,,,,,,,Lipofectamine,PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Neurite outgrowth was determined from low-density hippocampal neurons transfected with EGFP using Lipofectamine,0.85,Accept,Experimental Usage
RESe38e3fc5,shRNA,Plasmid,LT3GEPIR,,,,,,,shRNA,PMID:35789380 | PMID:26219339 | PMID:23685747 | PMID:41023593 | PMID:25772366,10.1158/2159-8290.CD-21-1671 | 10.18632/oncotarget.4858 | 10.1038/ng.2641 | 10.1186/s10020-025-01353-9 | 10.1016/j.celrep.2015.02.041,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Control (sh Ren.713), DNMT1, DNMT3A, and DNMT3B shRNAs were cloned into Tet-ON all-in-one plasmids LT3GEPIR (gift from Johannes Zuber, RRID:Addgene_111177) | 6,091 shRNAs, cloned into the pLKO-puromycin system | shRNA GIPZ lentiviral constructs were purchased from Openbiosystems | CRISPR-CAS9, and shRNA-mediated knockdown were used to perform gain/loss-of-function experiments to explore the effect of reconstituting the GTPase-activating protein-related domain of NF1 | Abcg1 shRNA or control shGFP-containing pLKO.1 plasmid was co-transfected",0.95,Accept,Experimental Usage
RESf7cc34f2,hGFAP-cre,Other,,,Human,,,,,hGFAP-cre,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,The control mice used in this study are a pool of phenotypically indistinguishable mice with genotypes of hGFAP-cre-; Nf1 flox/flox,0.9,Accept,Experimental Usage
RESc54d4fe5,Nf1 flox,,,,Mouse,,,,,Nf1 flox,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"mice with genotypes of hGFAP-cre-; Nf1 flox/flox , hGFAP-cre-; Nf1 flox/+ , hGFAP-cre+; Nf1 flox/+",0.95,Accept,Experimental Usage
RES42a9482e,Nf1 KO,,,,Mouse,,,,,Nf1 KO,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"hGFAP-cre±; Nf1 KO/+ . The mutant mice ( Nf1 hGFAP CKO) used were of the genotypes, hGFAP-cre+; Nf1 flox/KO",0.9,Accept,Experimental Usage
RES32a088fa,Nestin-cre ER,,,,Mouse,,,,,Nestin-cre ER,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"For inducible experiments, Nestin-cre ER +; Nf1 flox/+  (tamoxifen+) mice were used as controls while Nestin-cre ER +; Nf1 flox/flox",0.9,Accept,Experimental Usage
RES5e26f1a8,R26 LacZR,,,,Mouse,,,,,R26 LacZR,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,Both of inducible strains carry R26 LacZR  allele as a reporter.,0.85,Accept,Experimental Usage
RES3c86e21c,human neurofibromin,Plasmid,,,Human,,GFP,,,human neurofibromin,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"GFP-tagged human neurofibromin, transcript variant 1 cDNA (RG220425, Origene)",0.95,Accept,Experimental Usage
RES5783b081,human FBXW11,Plasmid,,,Human,,Myc-DDK,,,human FBXW11,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"Myc-DDK–tagged human FBXW11 transcript variant 3 cDNA (RC218905, Origene)",0.95,Accept,Experimental Usage
RESad01da66,Cre-GFP,Viral,AAV5,CMV,,,GFP,,,Cre-GFP,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"control (GFP; AAV5-CMV-GFP, UNC) or Cre-recombinase fused to GFP (CRE; AAV5-CMV-Cre-GFP, UNC)",0.95,Accept,Experimental Usage
RESb42186d8,NF1 capture probes,Other,,,,,,,,NF1 capture probes,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Capture probe set was designed and synthesized by Thermo Fisher Scientific for the Ion TargetSeq Custom Enrichment kit,0.9,Accept,Experimental Usage
RES94c0f4e7,Human All Exon,Other,,,,,,,,Human All Exon,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We performed exome sequencing on five malignant meningiomas on the Illumina HiSeq2000 platform using Agilent SureSelect Human All Exon kits.,0.9,Accept,Experimental Usage
RES77e25315,targeted region arrays,Other,,,,,,,,targeted region arrays,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"We next designed custom NimbleGen targeted region arrays on five candidate genes, and sequenced four additional malignant meningiomas.",0.85,Accept,Experimental Usage
RES101c52a5,COMT val158met probe,Other,,,,,,,,COMT val158met probe,PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,"Genotyping was performed using a real-time PCR system in the allelic discrimination mode...using the TaqMan Genotyping Master Mix (Applied Biosystems, Foster City, CA, USA)",0.85,Accept,Experimental Usage
RES3b400750,nuclear RFP,Viral,,EF1α,,,RFP,,,nuclear RFP,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Cell lines were transduced with Incucyte Nuclight Red Lentivirus (Sartorius, Gottingen, Germany) such that they will produce an EF1α promoter driven nuclear restricted red fluorescent label",0.9,Accept,Experimental Usage
RESf228eeaf,neurofibromin 2,Other,,,,,,,,neurofibromin 2,PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"Small interfering RNA (siRNA) molecules (neurofibromin 2 ON-TARGETplus SMARTpool; Dharmacon, Lafayette, CO) were diluted in Opti-MEM",0.95,Accept,Experimental Usage
REScb34c5cc,non-targeting control,Other,,,,,,,,non-targeting control,PMID:20195187 | PMID:33032988,10.1097/MAO.0b013e3181d2777f | 10.1158/0008-5472.CAN-20-1365,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"Transfection with a non-targeting, random sequence siRNA (Dharmacon) or Lipofectamine ™ 2000 alone served as separate negative controls. | RNAi was performed using ON-TARGETplus Non-targeting Pool (#D-001810–10-05, Dharmacon)",0.85,Accept,Experimental Usage
RESa52ab452,Ras Binding Domain,Other,,,,,,,,Ras Binding Domain,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"To determine the activity of Ras the EZ-Detect Ras Activation Kit (cat. 89855 from Pierce, Rockford, IL) was used",0.85,Accept,Experimental Usage
RES8722aa27,B-Raf,Other,,,,,,,AAAGAATTGGATCTGGATCAT,B-Raf,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"siRNA for either B-Raf: AAAGAATTGGATCTGGATCAT, and C-Raf: TGTGCGAAATGGAATGAGCTT, both from Dharmacon",0.9,Accept,Experimental Usage
RESe7f27bc5,C-Raf,Other,,,,,,,TGTGCGAAATGGAATGAGCTT,C-Raf,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"siRNA for either B-Raf: AAAGAATTGGATCTGGATCAT, and C-Raf: TGTGCGAAATGGAATGAGCTT, both from Dharmacon",0.9,Accept,Experimental Usage
RES0c4385ea,NF2 shRNA,Viral,Lentiviral,,,,,,ACTTCAAAGATA CTG ACAT,NF2 shRNA,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Lentiviral shRNA vectors were constructed using target sequences against the expression of NF2,0.9,Accept,Experimental Usage
RES0fa626bc,P53 shRNA,Viral,Lentiviral,,,,,,GA CTCCA GTGGT AA TCT A C,P53 shRNA,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,P53 (5′-GA CTCCA GTGGT AA TCT A C-3′),0.9,Accept,Experimental Usage
RESc66f3b31,P53,Plasmid,,,,,Flag,,,P53,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Flag-tagged P53 (Addgene; #10838),0.9,Accept,Experimental Usage
RESc421f3ce,CXCL12,Viral,,,Mouse,,,,,CXCL12,PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,Murine CXCL12 cDNA was subcloned into the lentiviral vector,0.85,Accept,Experimental Usage
RESf0cdca20,firefly luciferase-GFP fusion,Viral,,human ubiquitin-C,,,GFP,,,firefly luciferase-GFP fusion,PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,A second packaging vector (FUW-FLG) encoding a fusion of firefly luciferase and enhanced green fluorescent protein,0.85,Accept,Experimental Usage
RES66e53bd9,Spred1(EVH1),Plasmid,pET,,Human,,,,,Spred1(EVH1),PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,Construction of pET-Spred1(EVH1) encoding the EVH1 domain of human Spred1 (Ser13–Ser130) preceded by a non-native translation initiating methionine,0.85,Accept,Experimental Usage
RESdaa80ae1,FLAG,Plasmid,,,,,FLAG,,,FLAG,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,"Gateway LR recombination according to the manufacturer's protocol to insert NF1, SPRED1, and RAS entry clones into transient mammalian expression vectors pCAN-FLAG-DEST",0.8,Accept,Experimental Usage
RES34045619,HA,Plasmid,,,,,HA,,,HA,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,"Gateway LR recombination according to the manufacturer's protocol to insert NF1, SPRED1, and RAS entry clones into transient mammalian expression vectors pCAN-FLAG-DEST and pCAN-HA-DEST",0.8,Accept,Experimental Usage
RES82ed4d69,Tet-inducible,Viral,pLIX403,TRE3G,,,Puromycin,,,Tet-inducible,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,the lentiviral attR1-attR2 Gateway destination vector pLIX403 (Addgene 41395) was modified to attR4-attR2 by Gibson assembly,0.85,Accept,Experimental Usage
RES13b05979,packaging,Plasmid,psPAX2,,,,,,,packaging,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Lentiviral particles were then generated by equimolar cotransfection of these NF1 expression vectors with psPAX2 (Addgene 12260),0.8,Accept,Experimental Usage
RESd2303a47,envelope,Plasmid,pMD2.G,,,,,,,envelope,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Lentiviral particles were then generated by equimolar cotransfection of these NF1 expression vectors with psPAX2 (Addgene 12260) and pMD2.G (Addgene 12259) packaging plasmids,0.8,Accept,Experimental Usage
RESa7b33b2e,DNA capture system,Other,,,,,,,,DNA capture system,PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,NGS was performed by oligonucleotide hybridization‐based DNA capture (SureSelect; Agilent),0.8,Accept,Experimental Usage
RESa56acf38,Tet-pLKO-puro,Plasmid,pLKO,,,,Puromycin,,,Tet-pLKO-puro,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"shRNAs targeting PTPN11 #5003 and #818 were subcloned into Tet-pLKO-puro vector (Addgene, no. 21915)",0.85,Accept,Experimental Usage
RES53553b99,TTIGFP-MLUEX,Plasmid,,Tet-regulated promoter,,,GFP,,,TTIGFP-MLUEX,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,The human NF1-GRD was amplified using the genomic deoxyribonucleic acid (gDNA) from HEK293T as polymerase chain reaction template and subcloned into TTIGFP-MLUEX vector,0.85,Accept,Experimental Usage
RES4b3aca2c,shPTPN11,Plasmid,pLKO,Tet-regulated,,,,,,shPTPN11,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,shRNAs targeting PTPN11 #5003 and #818 were subcloned into Tet-pLKO-puro vector,0.9,Accept,Experimental Usage
RES75951cad,SB11,Other,,,Mouse,,,,,SB11,PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,a conditionally expressed SB transposase enzyme (R26-lsl-SB11),0.85,Accept,Experimental Usage
RESd71af387,T2/Onc15,Transposon,,,,,,,,T2/Onc15,PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,a concatomer of oncogenic transposons (T2/Onc15),0.85,Accept,Experimental Usage
RES8bac7882,EGFR,,,CNP,Human,,,,,EGFR,PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"MPNST predisposing alleles, Cnp-EGFR and conditional Trp53 alleles",0.85,Accept,Experimental Usage
RES7441e07c,FOXR2,Transposon,piggyBac,,,,Puromycin,,,FOXR2,PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,FOXR2 cDNA (Open Biosystems) was cloned into the Gateway Vector System (Invitrogen) and subcloned into a piggyBac (PB) transposon vector | TALENs targeting FOXR2 were designed using TALE-NT and constructed,0.85,Accept,Experimental Usage
RES537c99bb,HPRT,Other,,,,,,,,HPRT,PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,An HPRT TALEN pair served as a control,0.85,Accept,Experimental Usage
RES8b3eb9e0,KCNMA1,Other,,,,,,,,KCNMA1,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,QuantiTech Qiagen primers:  KCNMA1  (cat# QT00024157),0.9,Accept,Experimental Usage
RES04bb8752,PRKCE,Other,,,,,,,,PRKCE,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,PRKCE  (cat# QT00016352),0.9,Accept,Experimental Usage
RESfd2a9c90,OPCML,Other,,,,,,,,OPCML,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,OPCML  (cat# QT01005361),0.9,Accept,Experimental Usage
RES80efe2ec,GRIK2,Other,,,,,,,,GRIK2,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,GRIK2  (cat# QT00016597),0.9,Accept,Experimental Usage
RES65c51cf7,CADM2,Other,,,,,,,,CADM2,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,CADM2  (cat# QT00048888),0.9,Accept,Experimental Usage
RES9e76981a,CREB5,Other,,,,,,,,CREB5,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,CREB5  (cat# QT00054488),0.9,Accept,Experimental Usage
RESc1705075,CAMK1D,Other,,,,,,,,CAMK1D,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,CAMK1D  (cat# QT00036344),0.9,Accept,Experimental Usage
RESd2d95a42,ITGB8,Other,,,,,,,,ITGB8,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,ITGB8  (cat# QT00038507),0.9,Accept,Experimental Usage
RESad653dc1,Klenow (exo-),Other,,,,,,,,Klenow (exo-),PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"42 µl of end-repaired DNA was mixed with 5 µl of 10 X dA Tailing Reaction Buffer and 3 µl of Klenow (exo-)(cat# E6053, NEB, Ipswich, MA).",0.9,Accept,Experimental Usage
RESfa274add,anti-HER1 CAR 806,Viral,,,Human,,,,,anti-HER1 CAR 806,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"To target HER1, we constructed CARs using three distinct scFvs (806, E2 and NEC)",0.9,Accept,Development
RESb5824254,anti-HER1 CAR E2,Viral,,,Human,,,,,anti-HER1 CAR E2,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"To target HER1, we constructed CARs using three distinct scFvs (806, E2 and NEC)",0.9,Accept,Development
RES201f8b36,anti-HER1 CAR NEC,Viral,,,Human,,,,,anti-HER1 CAR NEC,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"To target HER1, we constructed CARs using three distinct scFvs (806, E2 and NEC)",0.9,Accept,Development
REScae79a31,AHR,Other,,,,,,,,AHR,PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,siRNA targeting...AHR (s1200),0.9,Accept,Experimental Usage
RES112d33ff,gRNA,Plasmid,,U6,,,,,,gRNA,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,U6-gRNA vectors were produced as previously described and introduced into iHSCs that are proficient for NF1,0.85,Accept,Experimental Usage
RESe51e6fc7,Luciferase-IRES-GFP,Transposon,,CAGG,,,Puromycin,,,Luciferase-IRES-GFP,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,co-transposition was performed using 500 ng of the piggyBac (PB) transposon PB-CAGG-Luciferase-IRES-GFP-PGK-PuroR,0.9,Accept,Experimental Usage
RES19a5ca87,PB7 transposase,,,CMV,,,,,,PB7 transposase,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,500 ng of CMV-PB7 transposase,0.85,Accept,Experimental Usage
RES0828ec0e,Human Universal Reference RNA,,,,Human,,,,,Human Universal Reference RNA,PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,"Sample RNA was processed in triplicate with serial dilutions of Human Universal Reference RNA (Stratagene, La Jolla, CA, USA)",0.75,Accept,Experimental Usage
RES2cea53d0,SGK1,Plasmid,pLKO,,,,Puromycin,,,SGK1,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,pLKO-puro-based shRNAs targeting human SGK1 (TRCN0000194957),0.9,Accept,Experimental Usage
RES03d91c64,PAK1,Plasmid,pLKO,,,,Puromycin,,,PAK1,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,human PAK1 (TRCN0000197238),0.9,Accept,Experimental Usage
RES26840da8,RHEB,Plasmid,pLKO,,,,Puromycin,,,RHEB,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,human RHEB (TRCN0000010424),0.9,Accept,Experimental Usage
RESa7f249ae,Ultra Low Cluster Plates,,,,,,,,,Ultra Low Cluster Plates,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,plated in 0.34% low melting temperature agarose (FMC Bioproducts) in complete medium at 2×10 4 (Meso-33 cells) or 1.2×10 4 (FC-1801 cells) per well in 24-well Ultra Low Cluster Plates (Costar).,0.75,Accept,Experimental Usage
RES125af38d,GST-PID,Plasmid,,,,,,,,GST-PID,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,A GST-PID (Pak1 amino acids 83–149) or Gst-PID L107F cDNA was subcloned,0.9,Accept,Experimental Usage
RES31f47e0c,Gst-PID L107F,Plasmid,,,,,,,,Gst-PID L107F,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,A GST-PID (Pak1 amino acids 83–149) or Gst-PID L107F cDNA was subcloned,0.9,Accept,Experimental Usage
RES12f322ef,PTPN11,Other,,,Human,,,,,PTPN11,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"SMARTPool ON-TARGETplus Human PTPN11 siRNA (#L-003947–00-0005, Dharmacon) to knockdown (KD) the expression of non-targeting control (NTC) and SHP2",0.9,Accept,Experimental Usage
RESa32cfd07,I2HCP panel,Other,,,,,,,,I2HCP panel,PMID:28051113 | PMID:36420221,10.1038/srep39348 | 10.1016/j.omtn.2022.10.026,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype",,"we developed the I2HCP panel, a custom bait library covering 122 hereditary cancer genes | Genetic testing was performed using the customized I2HCP panel in blood or tissue when available.",0.9,Accept,Development
RES33f252d2,shRNAs,Viral,,,,,,,,shRNAs,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"We infected secondary Nf1 neurofibroma spheres or fl/fl;DhhCre Stat3 DRG/neurofibroma spheres with shRNAs and non-target control (Sigma, St Louis, MO, USA)",0.85,Accept,Experimental Usage
RES1cd7b3a7,β-catenin ΔN90,Viral,,,,,,,,β-catenin ΔN90,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"β-catenin overexpression lentivirus ΔN90 (Addgene, Cambridge MA)",0.9,Accept,Experimental Usage
RES8d1863d3,D22S193,Other,,,,,,,,D22S193,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,checked for loss of heterozygosity in tumor DNA at markers D22S193 (centromeric to NF2),0.85,Accept,Experimental Usage
RES23ac5668,NF2 TET,Other,,,,,,,,NF2 TET,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"at markers D22S193 (centromeric to NF2), NF2 TET and D22S929 (intragenic)",0.85,Accept,Experimental Usage
RES977350e7,D22S929,Other,,,,,,,,D22S929,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"NF2 TET and D22S929 (intragenic), and D22S268 and D22S430",0.85,Accept,Experimental Usage
RESd9935604,D22S268,Other,,,,,,,,D22S268,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"D22S929 (intragenic), and D22S268 and D22S430 (telomeric to NF2)",0.85,Accept,Experimental Usage
RESe6f59aa8,D22S430,Other,,,,,,,,D22S430,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,and D22S268 and D22S430 (telomeric to NF2),0.85,Accept,Experimental Usage
RES7e1b1c54,BstUI,Other,,,,,,,,BstUI,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"PCR products were then digested using the endonuclease BstUI in 30 μl volumes according to the manufacturer's specifications (New England Biolabs, Beverly, MA)",0.9,Accept,Experimental Usage
RES91c49110,biocytin,,,,,,,,,biocytin,PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,0.2% biocytin was included in the intracellular pipette solution for later morphological identification,0.75,Accept,Experimental Usage
RESf210d6cb,NucLight red,Viral,,,,,Puromycin,,,NucLight red,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,Cell lines were infected with NucLight red lentivirus and stably selected in puromycin,0.85,Accept,Experimental Usage
RES6ab36ca5,HumanOmni2.5-8,Other,,,,,,,,HumanOmni2.5-8,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"SNP array sample prep was done using the HumanOmni2.5–8 (Illumina, Inc., San Diego, CA, USA)",0.85,Accept,Experimental Usage
RES3d4dd558,Endo-Porter,Other,,,,,,,,Endo-Porter,PMID:36420221 | PMID:29670214,10.1016/j.omtn.2022.10.026 | 10.1038/s41598-018-24310-5,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Restoring functional neurofibromin by protein transduction.,,"Endo-Porter (Gene Tools) was used as vehicle to deliver PMOs into cells at 6 μM | SynNF1 was transduced into fibroblasts using the transduction reagent EndoPorter (GeneTools, LLC)",0.85,Accept,Experimental Usage
RESb17781f7,interferon alpha-2b,Other,,,,,,,,interferon alpha-2b,PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,PEGylated interferon alpha-2b was purchased at the Cincinnati Children's Hospital (National Drug Code 00085132302) pharmacy,0.8,Accept,Experimental Usage
RES67b7afec,shSOX9,Viral,,,,,Puromycin,,,shSOX9,PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,we infected MPNST cells at 70–90% confluence with lentiviral particles containing shRNAs targeting SOX9 (Open Biosystems; TRC library),0.9,Accept,Experimental Usage
RES433a48c9,hTERT and mCdk4,Viral,pTYcPPT,EF1α,Human and Mouse,,,,,hTERT and mCdk4,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"The vector pTYcPPT, containing the elongation factor 1 alpha promoter, was used to separately clone hTERT and mCdk4",0.85,Accept,Experimental Usage
RES6de26181,hTERT,Viral,,,Human,,,,,hTERT,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,full length human telomerase reverse transcriptase cDNA,0.9,Accept,Experimental Usage
RESc2677df1,mCdk4,Viral,,,Mouse,,,,,mCdk4,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,murine Cdk4 full-length cDNA,0.9,Accept,Experimental Usage
RES81f2af23,KIF15/KIF23 siRNA,Other,,,,,,,,KIF15/KIF23 siRNA,PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,"siRNA pool targeting KIF15, KIF23, or a non-targeting control (NTC; siGENOME SMARTpool, Dharmacon)",0.9,Accept,Experimental Usage
RES5054f463,RGS2,Plasmid,,,,,,,,RGS2,PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,pRGS2 surrogate reporter (Labomics),0.9,Accept,Experimental Usage
RES2cfb93d4,ispinesib,,,,,,,,,ispinesib,PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,"ispinesib (Selleckchem) or ARRY-520 (MedChemExpress), which selectively inhibit KIF11",0.8,Accept,Experimental Usage
RES23b2c1c0,Merlin isoform 1,Plasmid,pET32a,,Human,,6XHis plus thioredoxin tag,,,Merlin isoform 1,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The human cDNA encoding the full-length Merlin isoform 1 was subcloned into the pET32a vector (EMD Biosciences, Inc), with a 6XHis plus thioredoxin tag",0.85,Accept,Experimental Usage
RES2f3f2a53,Merlin(S518D) and Merlin(S518E) mutants,Other,,,,,,,,Merlin(S518D) and Merlin(S518E) mutants,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The Merlin(S518D) and Merlin(S518E) mutants were generated with the QuikChange II site-directed mutagenesis kit (Agilent Technologies),0.8,Accept,Experimental Usage
RES69d1dc1f,HiTrap Chelating Sepharose™ High Performance,Other,,,,,,,,HiTrap Chelating Sepharose™ High Performance,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The supernatant ran through a 5 ml HiTrap Chelating Sepharose™ High Performance (GE healthcare) and washed extensively,0.75,Accept,Experimental Usage
RESfb6ee92d,Superdex 200 10/300 GL column,Other,,,,,,,,Superdex 200 10/300 GL column,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Further purification followed by gel filtration chromatography using a Superdex 200 10/300 GL column (GE Healthcare),0.75,Accept,Experimental Usage
RES9541c9a5,Gd-DTPA,,,,,,,,,Gd-DTPA,PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"all animals were intraperitoneally injected (1) a MR contrast agent, Gd-DTPA (Magnevist ®, Schering, Leverkusen, Germany) at a dose of 0.8 mL/kg",0.75,Accept,Experimental Usage
RES64881225,Human Mapping 100K Set,Other,,,,,,,,Human Mapping 100K Set,PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Tumor genotyping was performed with the Human Mapping 100K Set platform ( Affymetrix ),0.8,Accept,Experimental Usage
RESd6c8e47e,GeneChip Human Genome U133 Plus 2.0 Arrays,Other,,,,,,,,GeneChip Human Genome U133 Plus 2.0 Arrays,PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,gene-expression data were obtained using GeneChip Human Genome U133 Plus 2.0 Arrays ( Affymetrix ),0.8,Accept,Experimental Usage
RESc1550c66,PDE4A1,Viral,,,Mouse,,mCherry,,,PDE4A1,PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,Full-length murine PDE4A1 or catalytically inactive PDE4A1-H229Q was cloned into a lentiviral packaging vector that also encodes mCherry fluorescent protein,0.9,Accept,Development
RES1bcd1793,PDE4A1-H229Q,Viral,,,Mouse,,mCherry,,,PDE4A1-H229Q,PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,Full-length murine PDE4A1 or catalytically inactive PDE4A1-H229Q was cloned into a lentiviral packaging vector that also encodes mCherry fluorescent protein,0.9,Accept,Development
RES50652e79,firefly luciferase-eGFP fusion,Viral,FUW,human ubiquitin C,,,eGFP,,,firefly luciferase-eGFP fusion,PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,A second packaging vector (FUW-FLG) encoding a fusion of firefly luciferase and enhanced green fluorescent protein driven by the human ubiquitin C promoter,0.85,Accept,Experimental Usage
RES4f7ce1c9,PAM71,,,,,,,,,PAM71,PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,"PAM71 (MedChemExpress, catalog HY-134494), 8-(4-Chlorophenylthio)adenosine",0.9,Accept,Experimental Usage
RESb587ac38,Microsatellite markers,Other,,,,,,,,Microsatellite markers,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Loss of heterozygosity (LOH) in 22q was investigated using microsatellites D22S420, D22S539, D22S1174, D22S315, D22S1154, D22S1163, D22S280, D22S277, D22S283, D22S423, D22S274, and D22S1169 from the ABI PRISM Linkage Mapping set version 2.5",0.85,Accept,Experimental Usage
RES1bc23576,MLPA probe set,Other,,,,,,,,MLPA probe set,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"SMARCB1, NF2 and 22q11 MLPA test kits (MRC-Holland, P044_B1, P258_C1 and P324_A2) were used",0.85,Accept,Experimental Usage
RES0e1b9219,Kit Ligand,,,,,,,,,Kit Ligand,PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,"To determine if ketotifen had an in vivo effect on mast cell infiltration and degranulation, four-month old Nf1 mice were administered subcutaneous Kit Ligand as previously described",0.8,Accept,Experimental Usage
RES62860313,dCas9-BFP-KRAB,Plasmid,pMH0001,SFFV,,,BFP,,,dCas9-BFP-KRAB,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"Lentivirus containing pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB, #85969, Addgene) was produced",0.9,Accept,Experimental Usage
RESb80433db,TAZ,Plasmid,pLKO.1-puro,,,,Puromycin,,5′-CGGACTTCATTCAAGAGGAAT-3′,TAZ,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,TAZ (TRCN0000307197)—5′-CGGACTTCATTCAAGAGGAAT-3′,0.9,Accept,Experimental Usage
RES593ff8fa,YAP,Plasmid,pLKO.1-puro,,,,Puromycin,,5′-GCCACCAAGCTAGATAAAGAA-3′,YAP,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,YAP (TRCN0000107266)—5′-GCCACCAAGCTAGATAAAGAA-3′,0.9,Accept,Experimental Usage
RESae8f2761,Scramble,Plasmid,pLKO.1-puro,,,,Puromycin,,5′-CAACAAGATGAAGAGCACCAA-3′,Scramble,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Scramble (TRC1/1.5; SHC002)—5′-CAACAAGATGAAGAGCACCAA-3′,0.9,Accept,Experimental Usage
RESf0456171,Merlin siRNA,Other,,,,,,,,Merlin siRNA,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,Merlin knockdown U251-S cells were treated with siRNA SMARTpool (Thermo Scientific) directed to Merlin,0.85,Accept,Experimental Usage
RESd9daee7e,HA-Merlin,Plasmid,pXJ40,,,,,,,HA-Merlin,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,cells were transfected with pXJ40-HA-Merlin and S518A pXJ40- HA-Merlin,0.9,Accept,Experimental Usage
RES7ba0612d,S518A HA-Merlin,Plasmid,pXJ40,,,,,,,S518A HA-Merlin,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,cells were transfected with pXJ40-HA-Merlin and S518A pXJ40- HA-Merlin,0.9,Accept,Experimental Usage
RES32935ef7,IPA-3,,,,,,,,,IPA-3,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,Cells were treated with IPA-3 (Sigma-Aldrich) a PAK group1 inhibitor (PAK1/2/3),0.8,Accept,Experimental Usage
RES35f1da9f,PMOs,Other,,,Human,,,,,PMOs,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"The 25-mer-specific PMOs for four patients with splicing variants, and a pair of PMOs to induce exon skipping of exons 4, 8, and 11 of the NF2 gene were designed",0.9,Accept,Experimental Usage
RES8e3daffb,Gateway Gene Cloning system,Other,,,,,,,,Gateway Gene Cloning system,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,The NF2 gene was cloned using the Gateway Gene Cloning system (Invitrogen) after treatment to induce the exon-skipping to an FLAG Tag Expression Vector,0.9,Accept,Experimental Usage
RESba333718,FLAG Tag,Plasmid,,,,,FLAG,,,FLAG Tag,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,The NF2 gene was cloned using the Gateway Gene Cloning system (Invitrogen) after treatment to induce the exon-skipping to an FLAG Tag Expression Vector,0.9,Accept,Experimental Usage
RESd573c252,Lipofectamine LTX,Other,,,,,,,,Lipofectamine LTX,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"The expression vector was transfected into HeLa cells (Lipofectamine LTX with Plus Reagent, Invitrogen)",0.85,Accept,Experimental Usage
RES2948591f,NeuroD1,Viral,,CMV,,,,,,NeuroD1,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,"AdCMVNeuroD1 at 2 × 109 pfu/mL, or AdCMVNeuroD1 at 5 × 109 pfu/mL (ViraQuest, Inc.) were applied to the culture medium",0.9,Accept,Experimental Usage
RES98dd9a00,WC-10,,,,,,,,,WC-10,PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"[3H]-WC-10, and [3H]-a-Dihydrotetrabenazine ([3H]-DTBZ; American Radiolabeled Chemicals; St. Louis, MO)",0.85,Accept,Experimental Usage
RESae4ff0e7,telomere repeat sequence probe,,,,Human,,,,,telomere repeat sequence probe,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,hybridization with a Cy3-labeled peptide nucleic acid (PNA) probe complementary to the mammalian telomere repeat sequence [(N-terminus to C-terminus) CCCTAACCCTAACCCTAA],0.85,Accept,Experimental Usage
RESbe191704,centromeric DNA repeats probe,,,,Human,,,,,centromeric DNA repeats probe,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,an Alexa Fluor-488–labeled PNA probe specific to human centromeric DNA repeats was also included as a control to assess the validity of the hybridization,0.85,Accept,Experimental Usage
RESd90674c8,644 cancer gene panel,Other,,,,,,,,644 cancer gene panel,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,Genomic regions of interest were captured using an Agilent custom-designed bait set covering the full coding regions of 644 cancer associated genes,0.85,Accept,Experimental Usage
RESfad43e3a,Human Exome,Other,,,,,,,,Human Exome,PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"Whole-exome capture was performed using either the SeqCap EZ Human Exome Library (Nimblegen, Basel, Switzerland) | Whole-exome capture was performed using either the SeqCap EZ Human Exome Library (Nimblegen, Basel, Switzerland) or TruSeq Exome kit (Illumina, San Diego, CA)",0.85,Accept,Experimental Usage
RES1d7de0f3,pcDNA3.1,Plasmid,pcDNA3.1,,,,,,,pcDNA3.1,PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"PCR amplicons were cloned into pcDNA3.1 vector (Life Technologies, CA, USA)",0.9,Accept,Experimental Usage
RES39306a69,nf2a/b-4sgRNA,Plasmid,pGGDestTol2LC,,,,,,,nf2a/b-4sgRNA,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,All four guides were cloned into the final destination vector pGGDestTol2LC-4sgRNA (nf2a/b-4sgRNA),0.85,Accept,Experimental Usage
RES2bf6be74,DUSP6,,,,Pig,,,,,DUSP6,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,using the following pig TaqMan primers ( DUSP6 -Ss06941845_m1;  FOS  -Ss03390402_m1; normalized to the average of pig housekeeping genes,0.9,Accept,Experimental Usage
RES01d9e851,FOS,,,,Pig,,,,,FOS,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,using the following pig TaqMan primers ( DUSP6 -Ss06941845_m1;  FOS  -Ss03390402_m1; normalized to the average of pig housekeeping genes,0.9,Accept,Experimental Usage
RES50cd0dfe,Tp53,Other,,,,,,,,Tp53,PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,Cells were nucleofected with siRNA against Tp53 or miR34a (Dharmacon),0.9,Accept,Experimental Usage
RES4c563e63,miR34a,Other,,,,,,,,miR34a,PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,Cells were nucleofected with siRNA against Tp53 or miR34a (Dharmacon),0.9,Accept,Experimental Usage
RES9591bf70,PHA,Other,,,,,,,,PHA,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Lymphocyte growth was stimulated with 50 µl/ml PHA (Gibco),0.8,Accept,Experimental Usage
RES68caf748,IL-2,Other,,,,,,,,IL-2,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,stimulated with 50 µl/ml PHA (Gibco) and 10 units/ml of IL-2 (Roche),0.8,Accept,Experimental Usage
RES704417e9,MBP fusion,Plasmid,pMAL-c2X,,Human,,,,,MBP fusion,PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,The cDNA fragments were cloned in pMAL-c2X vector (New England Biolabs) for the expression of recombinant proteins as MBP fusions,0.8,Accept,Experimental Usage
RES6e71737e,His-p55,Other,,,,,,,,His-p55,PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,Bacterially expressed His-p55 was immobilized on the CM5 sensor chip,0.75,Accept,Experimental Usage
RES9e9c93db,REPLI-g FFPE,,,,,,,,,REPLI-g FFPE,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,genomic DNA was isolated and subjected to whole genome amplification according to manufacturers instructions using the REPLI-g FFPE kit (Qiagen),0.85,Accept,Experimental Usage
RES29ce008d,reprogramming factors,Viral,,,Human,,,,,reprogramming factors,PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,"The first vectors used to generate iPSCs were gamma retroviruses, specifically murine leukemia retroviruses, chosen for their favorable long-term transgene expression | Lentiviral vectors, a retroviral subclass, can transduce both non-dividing and rapidly-dividing cells with efficiencies comparable to other retroviruses | Adenoviral vectors are considered a non-integrative option for reprogramming factor delivery | Sendai viral vectors are another non-integrative reprogramming alternative",0.8,Accept,Experimental Usage
RES89d9331a,"OCT4, SOX2, MYC, KLF4, NANOG, LIN28",Plasmid,oriP/EBNA1,,Human,,,,,"OCT4, SOX2, MYC, KLF4, NANOG, LIN28",PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,"human fibroblasts have been successfully reprogrammed after a single transfection with oriP/EBNA1 (Epstein-Barr nuclear antigen-1)-based episomal vectors expressing OCT4, SOX2, MYC, KLF4, NANOG, LIN28",0.9,Accept,Experimental Usage
RESdfd13d05,1276P NF1 GRD,Viral,MSCV,,,,Puromycin,,,1276P NF1 GRD,PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,a virus expressing a GAP-inactive mutant of the NF1 GRD that harbors a known human mutation in the arginine finger loop (R1276P) and pac (MSCV-1276P NF1 GRD-pac),0.9,Accept,Experimental Usage
RES261f16c0,pac,Viral,MSCV,,,,Puromycin,,,pac,PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,a virus expressing the selectable marker gene alone (MSCV-pac),0.85,Accept,Experimental Usage
RES8db4245e,c-abl siRNA,Other,,,,,,,,c-abl siRNA,PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,"c-abl siRNA oligonucleotides (Cat. no. sc-29844) were purchased from Santa Cruz Biotechnology, Inc.",0.9,Accept,Experimental Usage
RES67c32bef,Scrambled siRNA,Other,,,,,,,,Scrambled siRNA,PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,Scrambled oligonucleotides (Cat. no. sc-36869) or vehicle only was used as controls,0.85,Accept,Experimental Usage
RES3875d4d9,Rictor,Viral,lentiviral,,,,GFP,,5′- ATAGCGCAGCGCTCGCAACC -3′,Rictor,PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"cells were transfected with the control lentivirus (LV-vector), NF-1 sgRNA-CAS9 lentivirus (LV-NF-1), Rictor sgRNA-CAS9 lentivirus (LV-Rictor)",0.9,Accept,Experimental Usage
RES3aedacc0,TUNEL,Other,,,,,,,,TUNEL,PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"The TUNEL assay was conducted by using the TUNEL kit (Roche, Reinach, Switzerland)",0.8,Accept,Experimental Usage
RES61413661,MSCV,Viral,,,,,,,,MSCV,PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,Murine stem cell virus (MSCV) infection was employed to express human WT or mutant (L64P patient mutation) merlin,0.85,Accept,Experimental Usage
RESec3d1b0e,Rac1 N17,,,,,,,,,Rac1 N17,PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,dominant-negative Rac1 (Rac1 N17) as previously described [15],0.85,Accept,Experimental Usage
RES2a762eb6,PLKO,Viral,,,,,,,,PLKO,PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,PLKO virus was used as an empty vector control,0.8,Accept,Experimental Usage
RES9b4eb071,Custom gene panel,Other,,,,,,,,Custom gene panel,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,Transcript level of the following genes were analyzed using an Illumina custom panel,0.85,Accept,Experimental Usage
RES5279b0f4,Alexa Fluor 594-labeled dextrans,,,,Unknown,,,,,Alexa Fluor 594-labeled dextrans,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"we electroporated the afferent fibers to the calyx of Held with Alexa Fluor 594-labeled dextrans (10,000 MW; Invitrogen)",0.9,Accept,Experimental Usage
RES96d1e455,CEP 8 (D8Z2),Other,,,,,,,,CEP 8 (D8Z2),PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Probes used were a centromeric-enumerating probe Vysis CEP 8 (D8Z2) SpectrumGreen combined with locus-specific probe,0.9,Accept,Experimental Usage
RESf4121132,LSI MYC,Other,,,,,,,,LSI MYC,PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,combined with locus-specific probe Vysis LSI MYC SpectrumOrange (Abbott Molecular),0.9,Accept,Experimental Usage
RES1a0a918e,PSME3,Plasmid,pSG5,SV40,,,G418,,,PSME3,PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,stably transfected with plasmid pSG5 vector and encoding PSME3 cDNA harbor PA28у cDNA under a constitutive SV40 promotor,0.85,Accept,Experimental Usage
RES0829546a,Cas9 and sgRNAs targeting Nf1+Cdkn2a,Viral,,,Mouse,,,,,Cas9 and sgRNAs targeting Nf1+Cdkn2a,PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,adenovirus containing Cas9 and sgRNAs targeting Nf1+Cdkn2a were produced,0.9,Accept,Experimental Usage
RESb75f9189,Ref-1,Other,,,,,,,,Ref-1,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"MPNST cells were transfected with Ref-1 #1 siRNA (sequence previously reported) | LifeTech validated Ref-1 siRNA (s1447, Santa Cruz, Dallas, TX, USA)",0.9,Accept,Experimental Usage
RES7b8cfac6,STAT3,Other,,,,,,,,STAT3,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"validated STAT3 siRNAs (sc-44275, sc-29493) and scrambled control",0.9,Accept,Experimental Usage
